{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T01:22:17Z","timestamp":1786324937845,"version":"build-2736575974"},"reference-count":252,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,2,10]],"date-time":"2025-02-10T00:00:00Z","timestamp":1739145600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100019274","name":"National Institute of Mental Health and Neurosciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100019274","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000057","name":"NIH National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["2K12GM106996"],"award-info":[{"award-number":["2K12GM106996"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000025","name":"National Institute of Mental Health","doi-asserted-by":"publisher","award":["R01MH106806"],"award-info":[{"award-number":["R01MH106806"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100030692","name":"Intramural Research Program, National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["R01DA053752"],"award-info":[{"award-number":["R01DA053752"]}],"id":[{"id":"10.13039\/100030692","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100030692","name":"Intramural Research Program, National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["R01DA45550"],"award-info":[{"award-number":["R01DA45550"]}],"id":[{"id":"10.13039\/100030692","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["pharmrev.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacological Reviews"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1016\/j.pharmr.2025.100046","type":"journal-article","created":{"date-parts":[[2025,2,10]],"date-time":"2025-02-10T11:53:07Z","timestamp":1739188387000},"page":"100046","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Safety in treatment: Classical pharmacotherapeutics and new avenues for addressing maternal depression and anxiety during pregnancy"],"prefix":"10.1016","volume":"77","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0325-4543","authenticated-orcid":false,"given":"Merel","family":"Dagher","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine M.","family":"Cahill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1961-4833","authenticated-orcid":false,"given":"Anne M.","family":"Andrews","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pharmr.2025.100046_bib1","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1146\/annurev-med-053013-062946","article-title":"Ketamine and rapid-acting antidepressants: A window into a new neurobiology for mood disorder therapeutics","volume":"66","author":"Abdallah","year":"2015","journal-title":"Annu Rev Med"},{"key":"10.1016\/j.pharmr.2025.100046_bib2","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.bbr.2006.02.012","article-title":"Vulnerability to mild predator stress in serotonin transporter knockout mice","volume":"170","author":"Adamec","year":"2006","journal-title":"Behav Brain Res"},{"key":"10.1016\/j.pharmr.2025.100046_bib3","series-title":"Drug Absorption","author":"Alagga","year":"2022"},{"key":"10.1016\/j.pharmr.2025.100046_bib4","doi-asserted-by":"crossref","first-page":"87","DOI":"10.25122\/jml-2020-0116","article-title":"The effect of ketamine on preventing postpartum depression","volume":"14","author":"Alipoor","year":"2021","journal-title":"J Med Life"},{"key":"10.1016\/j.pharmr.2025.100046_bib5","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1038\/npp.2014.331","article-title":"Perinatal vs genetic programming of serotonin states associated with anxiety","volume":"40","author":"Altieri","year":"2015","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pharmr.2025.100046_bib6","series-title":"Neurobiology of Depression","article-title":"Serotonergic pathways in depression","author":"Altieri","year":"2011"},{"key":"10.1016\/j.pharmr.2025.100046_bib7","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1038\/s44294-024-00008-0","article-title":"Antidepressant use during pregnancy and the risk of preterm birth\u2014a cohort study","volume":"2","author":"Amit","year":"2024","journal-title":"NPJ Womens Health"},{"key":"10.1016\/j.pharmr.2025.100046_bib8","doi-asserted-by":"crossref","first-page":"989","DOI":"10.2165\/00003088-200544100-00001","article-title":"Pregnancy-induced changes in pharmacokinetics: A mechanistic-based approach","volume":"44","author":"Anderson","year":"2005","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.pharmr.2025.100046_bib9","doi-asserted-by":"crossref","first-page":"e294","DOI":"10.4088\/JCP.17f11509","article-title":"Offspring outcomes in studies of antidepressant-treated pregnancies depend on the choice of control group","volume":"78","author":"Andrade","year":"2017","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.pharmr.2025.100046_bib10","doi-asserted-by":"crossref","first-page":"194.e1","DOI":"10.1016\/j.ajog.2007.07.036","article-title":"Use of antidepressant medications during pregnancy: A multisite study","volume":"198","author":"Andrade","year":"2008","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.pharmr.2025.100046_bib11","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1016\/S0022-3565(25)39594-7","volume":"267","author":"Andrews","year":"1993","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pharmr.2025.100046_bib12","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1038\/npp.2017.260","article-title":"Too depressed to swim or too afraid to stop? A reinterpretation of the forced swim test as a measure of anxiety-like behavior","volume":"43","author":"Anyan","year":"2018","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pharmr.2025.100046_bib13","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1089\/jwh.2006.0213","article-title":"Duloxetine for the treatment of fibromyalgia in women: Pooled results from two randomized, placebo-controlled clinical trials","volume":"16","author":"Arnold","year":"2007","journal-title":"J Womens Health (Larchmt)"},{"key":"10.1016\/j.pharmr.2025.100046_bib14","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.pain.2005.06.031","article-title":"A randomized, double-blind, placebo-controlled trial of duloxetine in the treatment of women with fibromyalgia with or without major depressive disorder","volume":"119","author":"Arnold","year":"2005","journal-title":"Pain"},{"key":"10.1016\/j.pharmr.2025.100046_bib15","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1124\/pr.111.005108","article-title":"Brain-derived neurotrophic factor and neuropsychiatric disorders","volume":"64","author":"Autry","year":"2012","journal-title":"Pharmacol Rev"},{"key":"10.1016\/j.pharmr.2025.100046_bib16","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1038\/s41380-021-01299-4","article-title":"Cross-species anxiety tests in psychiatry: Pitfalls and promises","volume":"27","author":"Bach","year":"2022","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.pharmr.2025.100046_bib17","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1177\/2045125314527985","article-title":"Classical hallucinogens as antidepressants? A review of pharmacodynamics and putative clinical roles","volume":"4","author":"Baumeister","year":"2014","journal-title":"Ther Adv Psychopharmacol"},{"key":"10.1016\/j.pharmr.2025.100046_bib18","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1007\/s11920-016-0664-7","article-title":"Depression during pregnancy and postpartum","volume":"18","author":"Becker","year":"2016","journal-title":"Curr Psychiatry Rep"},{"key":"10.1016\/j.pharmr.2025.100046_bib19","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1515\/intox-2017-0006","article-title":"Animal tests for anxiety-like and depression-like behavior in rats","volume":"10","author":"Belovicova","year":"2017","journal-title":"Interdiscip Toxicol"},{"key":"10.1016\/j.pharmr.2025.100046_bib20","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/S0006-3223(99)00230-9","article-title":"Antidepressant effects of ketamine in depressed patients","volume":"47","author":"Berman","year":"2000","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.pharmr.2025.100046_bib21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s40264-022-01257-1","article-title":"Should antidepressants be avoided in pregnancy?","volume":"46","author":"Besag","year":"2023","journal-title":"Drug Saf"},{"key":"10.1016\/j.pharmr.2025.100046_bib22","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1038\/mp.2008.119","article-title":"The mood-improving actions of antidepressants do not depend on neurogenesis but are associated with neuronal remodeling","volume":"14","author":"Bessa","year":"2009","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.pharmr.2025.100046_bib23","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1089\/jwh.2019.7781","article-title":"Psychotropic treatment during pregnancy: Research synthesis and clinical care principles","volume":"29","author":"Betcher","year":"2020","journal-title":"J Womens Health (Larchmt)"},{"key":"10.1016\/j.pharmr.2025.100046_bib24","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.neuropharm.2015.10.034","article-title":"BDNF\u2014a key transducer of antidepressant effects","volume":"102","author":"Bjorkholm","year":"2016","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pharmr.2025.100046_bib25","doi-asserted-by":"crossref","first-page":"e11","DOI":"10.1016\/j.biopsych.2012.02.039","article-title":"On the safety and benefits of repeated intravenous injections of ketamine for depression","volume":"72","author":"Blier","year":"2012","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.pharmr.2025.100046_bib26","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1038\/jp.2009.183","article-title":"Maternal\u2013fetal and neonatal pharmacogenomics: A review of current literature","volume":"30","author":"Blumenfeld","year":"2010","journal-title":"J Perinatol"},{"key":"10.1016\/j.pharmr.2025.100046_bib27","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1016\/j.euroneuro.2006.04.010","article-title":"Electroconvulsive therapy (ECT) increases serum brain derived neurotrophic factor (BDNF) in drug resistant depressed patients","volume":"16","author":"Bocchio-Chiavetto","year":"2006","journal-title":"Eur Neuropsychopharmacol"},{"key":"10.1016\/j.pharmr.2025.100046_bib28","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1124\/pr.111.005207","article-title":"Prenatal antidepressant exposure: Clinical and preclinical findings","volume":"66","author":"Bourke","year":"2014","journal-title":"Pharmacol Rev"},{"key":"10.1016\/j.pharmr.2025.100046_bib29","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1056\/NEJMra041867","article-title":"The serotonin syndrome","volume":"352","author":"Boyer","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.pharmr.2025.100046_bib30","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1038\/s41598-018-38304-w","article-title":"Inflammatory and anti-inflammatory markers in plasma: From late pregnancy to early postpartum","volume":"9","author":"Br\u00e4nn","year":"2019","journal-title":"Sci Rep"},{"key":"10.1016\/j.pharmr.2025.100046_bib31","first-page":"e6","article-title":"Mood disorders in women: Focus on reproductive psychiatry in the 21st century\u2014motherisk update 2008","volume":"16","author":"Burt","year":"2009","journal-title":"Can J Clin Pharmacol"},{"key":"10.1016\/j.pharmr.2025.100046_bib32","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1038\/s41386-022-01309-1","article-title":"What\u2019s wrong with my experiment? The impact of hidden variables on neuropsychopharmacology research","volume":"47","author":"Butler-Struben","year":"2022","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pharmr.2025.100046_bib33","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1111\/acps.12042","article-title":"Antidepressant use in pregnancy: A critical review focused on risks and controversies","volume":"127","author":"Byatt","year":"2013","journal-title":"Acta Psychiatr Scand"},{"key":"10.1016\/j.pharmr.2025.100046_bib34","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1038\/s41586-020-3008-z","article-title":"A non-hallucinogenic psychedelic analogue with therapeutic potential","volume":"589","author":"Cameron","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.pharmr.2025.100046_bib35","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1176\/appi.ajp.2018.17060720","article-title":"Efficacy and safety of intranasal esketamine for the rapid reduction of symptoms of depression and suicidality in patients at imminent risk for suicide: Results of a double-blind, randomized, placebo-controlled study","volume":"175","author":"Canuso","year":"2018","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.pharmr.2025.100046_bib36","doi-asserted-by":"crossref","first-page":"E6","DOI":"10.3171\/2017.6.FOCUS17257","article-title":"Psychosurgery, ethics, and media: A history of walter freeman and the lobotomy","volume":"43","author":"Caruso","year":"2017","journal-title":"Neurosurg Focus"},{"key":"10.1016\/j.pharmr.2025.100046_bib37","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.tins.2012.12.010","article-title":"Neuronal plasticity and antidepressant actions","volume":"36","author":"Castr\u00e9n","year":"2013","journal-title":"Trends Neurosci"},{"key":"10.1016\/j.pharmr.2025.100046_bib38","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.jad.2018.12.028","article-title":"Promoting the well-being of mothers with multidisciplinary psychosocial interventions in the perinatal period","volume":"246","author":"Cauli","year":"2019","journal-title":"J Affect Disord"},{"key":"10.1016\/j.pharmr.2025.100046_bib39","series-title":"Pharmacotherapy for Stimulant Use Disorders: A Systematic Review","author":"Chan","year":"2018"},{"key":"10.1016\/j.pharmr.2025.100046_bib40","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1176\/ajp.113.1.32","article-title":"Transorbital lobotomy versus electroconvulsive therapy in the treatment of mentally ill tuberculous patients","volume":"113","author":"Cheng","year":"1956","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.pharmr.2025.100046_bib41","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2019.00138","article-title":"Effects of perinatal exposure to ketamine on the developing brain","volume":"13","author":"Cheung","year":"2019","journal-title":"Front Neurosci"},{"key":"10.1016\/j.pharmr.2025.100046_bib42","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.psyneuen.2016.08.025","article-title":"Serum brain-derived neurotrophic factor (bdnf) across pregnancy and postpartum: Associations with race, depressive symptoms, and low birth weight","volume":"74","author":"Christian","year":"2016","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.pharmr.2025.100046_bib43","series-title":"Selective Serotonin Reuptake Inhibitors","author":"Chu","year":"2024"},{"key":"10.1016\/j.pharmr.2025.100046_bib44","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1016\/j.ajog.2004.09.027","article-title":"Pregnancy outcome of women exposed to bupropion during pregnancy: A prospective comparative study","volume":"192","author":"Chun-Fai-Chan","year":"2005","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.pharmr.2025.100046_bib45","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1016\/S0140-6736(17)32802-7","article-title":"Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: A systematic review and network meta-analysis","volume":"391","author":"Cipriani","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.pharmr.2025.100046_bib46","doi-asserted-by":"crossref","first-page":"1988","DOI":"10.1016\/j.clinthera.2008.11.009","article-title":"Milnacipran for the treatment of fibromyalgia in adults: A 15-week, multicenter, randomized, double-blind, placebo-controlled, multiple-dose clinical trial","volume":"30","author":"Clauw","year":"2008","journal-title":"Clin Ther"},{"key":"10.1016\/j.pharmr.2025.100046_bib47","doi-asserted-by":"crossref","first-page":"62","DOI":"10.4088\/JCP.v65n0110","article-title":"A placebo-controlled trial of bupropion sr as an antidote for selective serotonin reuptake inhibitor-induced sexual dysfunction","volume":"65","author":"Clayton","year":"2004","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.pharmr.2025.100046_bib48","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1192\/bjp.113.504.1237","article-title":"The biochemistry of affective disorders","volume":"113","author":"Coppen","year":"1967","journal-title":"Br J Psychiatry"},{"key":"10.1016\/j.pharmr.2025.100046_bib49","first-page":"16","article-title":"Understanding the impact of stigma on people with mental illness","volume":"1","author":"Corrigan","year":"2002","journal-title":"World Psychiatry"},{"key":"10.1016\/j.pharmr.2025.100046_bib50","doi-asserted-by":"crossref","first-page":"65","DOI":"10.3389\/fphar.2014.00065","article-title":"Physiologic and pharmacokinetic changes in pregnancy","volume":"5","author":"Costantine","year":"2014","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.pharmr.2025.100046_bib51","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1177\/1753495x12473751","article-title":"Effects of prenatal stress on pregnancy and human development: Mechanisms and pathways","volume":"6","author":"Coussons-Read","year":"2013","journal-title":"Obstet Med"},{"key":"10.1016\/j.pharmr.2025.100046_bib52","doi-asserted-by":"crossref","first-page":"235","DOI":"10.3390\/brainsci9090235","article-title":"Use of prescribed psychotropics during pregnancy: A systematic review of pregnancy, neonatal, and childhood outcomes","volume":"9","author":"Creeley","year":"2019","journal-title":"Brain Sci"},{"key":"10.1016\/j.pharmr.2025.100046_bib53","first-page":"28","article-title":"Vilazodone HCl (Viibryd): A serotonin partial agonist and reuptake inhibitor for the treatment of major depressive disorder","volume":"37","author":"Cruz","year":"2012","journal-title":"Pharm Ther"},{"key":"10.1016\/j.pharmr.2025.100046_bib54","doi-asserted-by":"crossref","first-page":"221","DOI":"10.2967\/jnmt.117.199638","article-title":"Pharmacology, part 2: Introduction to pharmacokinetics","volume":"46","author":"Currie","year":"2018","journal-title":"J Nucl Med Technol"},{"key":"10.1016\/j.pharmr.2025.100046_bib55","first-page":"36","article-title":"Vortioxetine (brintellix): A new serotonergic antidepressant","volume":"40","author":"D\u2019Agostino","year":"2015","journal-title":"Pharm Ther"},{"key":"10.1016\/j.pharmr.2025.100046_bib56","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1021\/acschemneuro.1c00715","article-title":"Optogenetic stimulation of midbrain dopamine neurons produces striatal serotonin release","volume":"13","author":"Dagher","year":"2022","journal-title":"ACS Chem Neurosci"},{"key":"10.1016\/j.pharmr.2025.100046_bib57","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1001\/jamapsychiatry.2017.3739","article-title":"Efficacy and safety of intranasal esketamine adjunctive to oral antidepressant therapy in treatment-resistant depression: A randomized clinical trial","volume":"75","author":"Daly","year":"2018","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.pharmr.2025.100046_bib58","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.neuron.2009.04.017","article-title":"Neurogenesis-dependent and -independent effects of fluoxetine in an animal model of anxiety\/depression","volume":"62","author":"David","year":"2009","journal-title":"Neuron"},{"key":"10.1016\/j.pharmr.2025.100046_bib59","doi-asserted-by":"crossref","first-page":"e78","DOI":"10.1097\/AOG.0000000000005488","article-title":"Maternal mortality: A national institutes of health pathways to prevention panel report","volume":"143","author":"Davidson","year":"2024","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.pharmr.2025.100046_bib60","doi-asserted-by":"crossref","first-page":"41","DOI":"10.15585\/mmwr.mm6503a1","article-title":"Antidepressant prescription claims among reproductive-aged women with private employer-sponsered insurance\u2014United States 2008-2013","volume":"65","author":"Dawson","year":"2016","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.pharmr.2025.100046_bib61","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1097\/JCP.0000000000000087","article-title":"Pharmacotherapy for mood disorders in pregnancy: A review of pharmacokinetic changes and clinical recommendations for therapeutic drug monitoring","volume":"34","author":"Deligiannidis","year":"2014","journal-title":"J Clin Psychopharmacol"},{"key":"10.1016\/j.pharmr.2025.100046_bib62","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/0010-440X(92)90007-D","article-title":"The role of dopamine in mood disorders","volume":"33","author":"Diehl","year":"1992","journal-title":"Compr Psychiatry"},{"key":"10.1016\/j.pharmr.2025.100046_bib63","doi-asserted-by":"crossref","first-page":"12","DOI":"10.3389\/fphys.2016.00012","article-title":"Placental responses to changes in the maternal environment determine fetal growth","volume":"7","author":"Dimasuay","year":"2016","journal-title":"Front Physiol"},{"key":"10.1016\/j.pharmr.2025.100046_bib64","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1089\/jwh.2020.8863","article-title":"U.S. Maternal mortality within a global context: Historical trends, current state, and future directions","volume":"30","author":"Douthard","year":"2021","journal-title":"J Womens Health (Larchmt)"},{"key":"10.1016\/j.pharmr.2025.100046_bib65","doi-asserted-by":"crossref","first-page":"409","DOI":"10.3109\/14767050903168424","article-title":"Transplacental transfer and metabolism of bupropion","volume":"23","author":"Earhart","year":"2010","journal-title":"J Matern Fetal Neonatal Med"},{"key":"10.1016\/j.pharmr.2025.100046_bib66","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1111\/j.1399-6576.1977.tb01191.x","article-title":"Transplacental passage of ketamine after intravenous administration","volume":"21","author":"Ellingson","year":"1977","journal-title":"Acta Anaesthesiol Scand"},{"key":"10.1016\/j.pharmr.2025.100046_bib67","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1111\/aogs.12611","article-title":"No association between prenatal exposure to psychotropics and intelligence at age five","volume":"94","author":"Eriksen","year":"2015","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1016\/j.pharmr.2025.100046_bib68","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.psychres.2007.09.007","article-title":"Comorbidity of depressive disorders among adolescents in community and clinical settings","volume":"158","author":"Essau","year":"2008","journal-title":"Psychiatry Res"},{"key":"10.1016\/j.pharmr.2025.100046_bib69","series-title":"Stimulants","author":"Farzam","year":"2022"},{"key":"10.1016\/j.pharmr.2025.100046_bib70","series-title":"FDA Approves First Treatment for Post-partum Depression","year":"2019"},{"key":"10.1016\/j.pharmr.2025.100046_bib71","series-title":"FDA Approves New Nasal Spray Medication for Treatment-Resistant Depression; Available Only at a Certified Doctor\u2019s Office or Clinic","year":"2019"},{"key":"10.1016\/j.pharmr.2025.100046_bib72","series-title":"FDA Drug Safety Communication: Selective Serotonin Reuptake Inhibitor (SSRI) Antidepressant Use During Pregnancy and Reports of a Rare Heart and Lung Condition in Newborn Babies","year":"2018"},{"key":"10.1016\/j.pharmr.2025.100046_bib73","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1053\/j.semperi.2015.08.003","article-title":"Pharmacokinetics of drugs in pregnancy","volume":"39","author":"Feghali","year":"2015","journal-title":"Semin Perinatol"},{"key":"10.1016\/j.pharmr.2025.100046_bib74","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1016\/j.tips.2011.08.005","article-title":"Cytochrome p450 enzymes in the brain: Emerging evidence of biological significance","volume":"32","author":"Ferguson","year":"2011","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.pharmr.2025.100046_bib75","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1146\/annurev.ne.14.030191.001251","article-title":"Neurotransmitters in nociceptive modulatory circuits","volume":"14","author":"Fields","year":"1991","journal-title":"Ann Rev Neurosci"},{"key":"10.1016\/j.pharmr.2025.100046_bib76","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1586\/14737175.6.9.1249","article-title":"Bupropion: Pharmacology and therapeutic applications","volume":"6","author":"Foley","year":"2006","journal-title":"Expert Rev Neurother"},{"key":"10.1016\/j.pharmr.2025.100046_bib77","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1017\/S146114570900011X","article-title":"Tramadol and another atypical opioid meperidine have exaggerated serotonin syndrome behavioural effects, but decreased analgesic effects, in genetically deficient serotonin transporter (SERT) mice","volume":"12","author":"Fox","year":"2009","journal-title":"Int J Neuropsychopharmacol"},{"key":"10.1016\/j.pharmr.2025.100046_bib78","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1038\/pr.2017.156","article-title":"Neonatal adaptation following intrauterine antidepressant exposure: Assessment, drug assay levels, and infant development outcomes","volume":"82","author":"Galbally","year":"2017","journal-title":"Pediatr Res"},{"key":"10.1016\/j.pharmr.2025.100046_bib79","doi-asserted-by":"crossref","first-page":"137","DOI":"10.2165\/00002018-200528020-00005","article-title":"The safety of newer antidepressants in pregnancy and breastfeeding","volume":"28","author":"Gentile","year":"2005","journal-title":"Drug Saf"},{"key":"10.1016\/j.pharmr.2025.100046_bib80","doi-asserted-by":"crossref","first-page":"623","DOI":"10.2165\/00023210-200519070-00004","article-title":"SSRIs in pregnancy and lactation: Emphasis on neurodevelopmental outcome","volume":"19","author":"Gentile","year":"2005","journal-title":"CNS Drugs"},{"key":"10.1016\/j.pharmr.2025.100046_bib81","doi-asserted-by":"crossref","first-page":"291","DOI":"10.31887\/DCNS.2008.10.3\/pgorwood","article-title":"Neurobiological mechanisms of anhedonia","volume":"10","author":"Gorwood","year":"2008","journal-title":"Dial Clin Neurosci"},{"key":"10.1016\/j.pharmr.2025.100046_bib82","doi-asserted-by":"crossref","first-page":"13208","DOI":"10.1073\/pnas.0605180103","article-title":"Transgenic brain-derived neurotrophic factor expression causes both anxiogenic and antidepressant effects","volume":"103","author":"Govindarajan","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.pharmr.2025.100046_bib83","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1038\/nrd4075","article-title":"50 years of hurdles and hope in anxiolytic drug discovery","volume":"12","author":"Griebel","year":"2013","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.pharmr.2025.100046_bib84","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1007\/s12630-018-1172-5","article-title":"In asking the right questions, be cautious of confounding by indication","volume":"65","author":"Griesdale","year":"2018","journal-title":"Can J Anaesth"},{"key":"10.1016\/j.pharmr.2025.100046_bib85","first-page":"84","article-title":"Placental structure, function and drug transfer","volume":"15","author":"Griffiths","year":"2015","journal-title":"Contin Educ Anaesth Crit Care Pain"},{"key":"10.1016\/j.pharmr.2025.100046_bib86","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1186\/1471-2393-14-242","article-title":"Patterns of psychotropic medicine use in pregnancy in the United States from 2006 to 2011 among women with private insurance","volume":"14","author":"Hanley","year":"2014","journal-title":"BMC Pregnancy Childbirth"},{"key":"10.1016\/j.pharmr.2025.100046_bib87","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.neuropharm.2018.01.049","article-title":"Evaluating the abuse potential of psychedelic drugs as part of the safety pharmacology assessment for medical use in humans","volume":"142","author":"Heal","year":"2018","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pharmr.2025.100046_bib88","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1176\/appi.ajp.160.5.993","article-title":"Placental passage of antidepressant medications","volume":"160","author":"Hendrick","year":"2003","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.pharmr.2025.100046_bib89","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/S0163-7258(99)00048-0","article-title":"Pharmacokinetics of selective serotonin reuptake inhibitors","volume":"85","author":"Hiemke","year":"2000","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.pharmr.2025.100046_bib90","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1007\/s10608-012-9476-1","article-title":"The efficacy of cognitive behavioral therapy: A review of meta-analyses","volume":"36","author":"Hofmann","year":"2012","journal-title":"Cognit Ther Res"},{"key":"10.1016\/j.pharmr.2025.100046_bib91","first-page":"87","article-title":"The psychedelic renaissance and its forensic implications","volume":"48","author":"Holoyda","year":"2020","journal-title":"J Am Acad Psychiatry Law"},{"key":"10.1016\/j.pharmr.2025.100046_bib92","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1016\/S0006-3223(00)00958-6","article-title":"Amniotic fluid and umbilical cord blood concentrations of antidepressants in three women","volume":"48","author":"Hostetter","year":"2000","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.pharmr.2025.100046_bib93","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.earlhumdev.2018.10.009","article-title":"A 6-year longitudinal study: Are maternal depressive symptoms and selective serotonin reuptake inhibitor (SSRI) antidepressant treatment during pregnancy associated with everyday measures of executive function in young children?","volume":"128","author":"Hutchison","year":"2019","journal-title":"Early Hum Dev"},{"key":"10.1016\/j.pharmr.2025.100046_bib94","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1097\/DBP.0000000000000658","article-title":"Impact of prenatal selective serotonin reuptake inhibitor antidepressant exposure and maternal mood on physical activity, dietary intake, and markers of adiposity at age 6 years","volume":"40","author":"Hutchison","year":"2019","journal-title":"J Dev Behav Pediatr"},{"key":"10.1016\/j.pharmr.2025.100046_bib95","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1124\/dmd.112.050245","article-title":"Drug metabolism and transport during pregnancy: How does drug disposition change during pregnancy and what are the mechanisms that cause such changes?","volume":"41","author":"Isoherranen","year":"2013","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.pharmr.2025.100046_bib96","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1080\/02791072.2001.10400480","article-title":"The nonmedical use of ketamine, part two: A review of problem use and dependence","volume":"33","author":"Jansen","year":"2001","journal-title":"J Psychoact Drugs"},{"key":"10.1016\/j.pharmr.2025.100046_bib97","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1080\/02791072.2000.10400244","article-title":"A review of the nonmedical use of ketamine: Use, users and consequences","volume":"32","author":"Jansen","year":"2000","journal-title":"J Psychoact Drugs"},{"key":"10.1016\/j.pharmr.2025.100046_bib98","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1016\/j.clinthera.2005.11.011","article-title":"Bupropion for major depressive disorder: Pharmacokinetic and formulation considerations","volume":"27","author":"Jefferson","year":"2005","journal-title":"Clin Ther"},{"key":"10.1016\/j.pharmr.2025.100046_bib99","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1517\/17425251003677755","article-title":"Altered drug metabolism during pregnancy: Hormonal regulation of drug-metabolizing enzymes","volume":"6","author":"Jeong","year":"2010","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"10.1016\/j.pharmr.2025.100046_bib100","article-title":"Exposure to antidepressants during pregnancy\u2014prevalences and outcomes","volume":"61","author":"Jimenez-Solem","year":"2014","journal-title":"Dan Med J"},{"key":"10.1016\/j.pharmr.2025.100046_bib101","doi-asserted-by":"crossref","first-page":"e785","DOI":"10.4088\/JCP.13m08725","article-title":"Safety, tolerability, and clinical effect of low-dose buprenorphine for treatment-resistant depression in midlife and older adults","volume":"75","author":"Karp","year":"2014","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.pharmr.2025.100046_bib102","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1038\/s41380-019-0585-z","article-title":"Prospective biomarkers of major depressive disorder: A systematic review and meta-analysis","volume":"25","author":"Kennis","year":"2020","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.pharmr.2025.100046_bib103","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1192\/bjp.186.3.190","article-title":"Personality and comorbidity of common psychiatric disorders","volume":"186","author":"Khan","year":"2005","journal-title":"Br J Psychiatry"},{"key":"10.1016\/j.pharmr.2025.100046_bib104","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/toxsci\/kfr088","article-title":"Thalidomide: The tragedy of birth defects and the effective treatment of disease","volume":"122","author":"Kim","year":"2011","journal-title":"Toxicol Sci"},{"key":"10.1016\/j.pharmr.2025.100046_bib105","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1038\/s41593-021-00868-8","article-title":"Sustained effects of rapidly acting antidepressants require BDNF-dependent MeCP2 phosphorylation","volume":"24","author":"Kim","year":"2021","journal-title":"Nat Neurosci"},{"key":"10.1016\/j.pharmr.2025.100046_bib106","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1111\/1471-0528.16772","article-title":"Antidepressant use in pregnancy and severe cardiac malformations: Danish register-based study","volume":"128","author":"Kolding","year":"2021","journal-title":"BJOG"},{"key":"10.1016\/j.pharmr.2025.100046_bib107","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/7854_2010_108","article-title":"Animal models of depression: Molecular perspectives","volume":"7","author":"Krishnan","year":"2011","journal-title":"Curr Topics Behav Neurosci"},{"key":"10.1016\/j.pharmr.2025.100046_bib108","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1038\/s41591-020-0806-7","article-title":"A randomized proof-of-mechanism trial applying the \u2018fast-fail\u2019 approach to evaluating kappa-opioid antagonism as a treatment for anhedonia","volume":"26","author":"Krystal","year":"2020","journal-title":"Nat Med"},{"key":"10.1016\/j.pharmr.2025.100046_bib109","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1097\/GRF.0b013e31815a5494","article-title":"Metabolic changes in pregnancy","volume":"50","author":"Lain","year":"2007","journal-title":"Clin Obstet Gynecol"},{"key":"10.1016\/j.pharmr.2025.100046_bib110","doi-asserted-by":"crossref","first-page":"170","DOI":"10.3389\/fpsyt.2014.00170","article-title":"The kappa opioid receptor: From addiction to depression, and back","volume":"5","author":"Lalanne","year":"2014","journal-title":"Front Psychiatry"},{"key":"10.1016\/j.pharmr.2025.100046_bib111","first-page":"239","article-title":"FDA pregnancy risk categories and the cps: Do they help or are they a hindrance?","volume":"56","author":"Law","year":"2010","journal-title":"Can Fam Physician"},{"key":"10.1016\/j.pharmr.2025.100046_bib112","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/0014-2999(88)90543-2","article-title":"Buprenorphine is a potent \u03ba-opioid receptor antagonist in pigeons and mice","volume":"151","author":"Leander","year":"1988","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pharmr.2025.100046_bib113","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1038\/515182a","article-title":"Medical research: If depression were cancer","volume":"515","author":"Ledford","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.pharmr.2025.100046_bib114","doi-asserted-by":"crossref","first-page":"873","DOI":"10.30773\/pi.2022.0209","article-title":"Confounding by indication in studies of selective serotonin reuptake inhibitors","volume":"19","author":"Lee","year":"2022","journal-title":"Psychiatry Investig"},{"key":"10.1016\/j.pharmr.2025.100046_bib115","doi-asserted-by":"crossref","first-page":"2229","DOI":"10.1007\/s00127-022-02331-w","article-title":"Mental health service use among pregnant and early postpartum women","volume":"57","author":"Lee-Carbon","year":"2022","journal-title":"Soc Psychiatry Psychiatr Epidemiol"},{"key":"10.1016\/j.pharmr.2025.100046_bib116","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1097\/jcp.0b013e31815ac4d2","article-title":"Delivery outcome in relation to maternal use of some recently introduced antidepressants","volume":"27","author":"Lennest\u00e5l","year":"2007","journal-title":"J Clin Psychopharmacol"},{"key":"10.1016\/j.pharmr.2025.100046_bib117","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1038\/s41372-020-0598-0","article-title":"Maternal use of selective serotonin reuptake inhibitors (ssri) during pregnancy\u2014neonatal outcomes in correlation with placental histopathology","volume":"40","author":"Levy","year":"2020","journal-title":"J Perinatol"},{"key":"10.1016\/j.pharmr.2025.100046_bib118","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1093\/ije\/dyp200","article-title":"Elevated maternal cortisol levels during pregnancy are associated with reduced childhood IQ","volume":"38","author":"LeWinn","year":"2009","journal-title":"Int J Epidemiol"},{"key":"10.1016\/j.pharmr.2025.100046_bib119","doi-asserted-by":"crossref","first-page":"181","DOI":"10.31887\/DCNS.2017.19.2\/wcarlezon","article-title":"Behavioral methods to study anxiety in rodents","volume":"19","author":"Lezak","year":"2017","journal-title":"Dial Clin Neurosci"},{"key":"10.1016\/j.pharmr.2025.100046_bib120","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1126\/science.1190287","article-title":"mTOR-dependent synapse formation underlies the rapid antidepressant effects of nmda antagonists","volume":"329","author":"Li","year":"2010","journal-title":"Science"},{"key":"10.1016\/j.pharmr.2025.100046_bib121","first-page":"4","article-title":"Major depressive disorder and kappa opioid receptor antagonists","volume":"1","author":"Li","year":"2016","journal-title":"Transl Perioper Pain Med"},{"key":"10.1016\/j.pharmr.2025.100046_bib122","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/s00737-005-0080-1","article-title":"Prevalence of suicidality during pregnancy and the postpartum","volume":"8","author":"Lindahl","year":"2005","journal-title":"Arch Womens Ment Health"},{"key":"10.1016\/j.pharmr.2025.100046_bib123","doi-asserted-by":"crossref","first-page":"305","DOI":"10.3389\/fncel.2017.00305","article-title":"From serotonin to neuroplasticity: Evolvement of theories for major depressive disorder","volume":"11","author":"Liu","year":"2017","journal-title":"Front Cell Neurosci"},{"key":"10.1016\/j.pharmr.2025.100046_bib124","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1080\/10401230591002002","article-title":"History of the discovery and clinical introduction of chlorpromazine","volume":"17","author":"L\u00f3pez-Mu\u00f1oz","year":"2005","journal-title":"Ann Clin Psychiatry"},{"key":"10.1016\/j.pharmr.2025.100046_bib125","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1176\/appi.ajp.163.1.145","article-title":"Antidepressants in amniotic fluid: Another route of fetal exposure","volume":"163","author":"Loughhead","year":"2006","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.pharmr.2025.100046_bib126","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1002\/jcph.286","article-title":"Safety, tolerability, and pharmacokinetic evaluation of single- and multiple-ascending doses of a novel kappa opioid receptor antagonist LY2456302 and drug interaction with ethanol in healthy subjects","volume":"54","author":"Lowe","year":"2014","journal-title":"J Clin Pharmacol"},{"key":"10.1016\/j.pharmr.2025.100046_bib127","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1111\/j.1601-183X.2006.00279.x","article-title":"Reduced brain-derived neurotrophic factor is associated with a loss of serotonergic innervation in the hippocampus of aging mice","volume":"6","author":"Luellen","year":"2007","journal-title":"Genes Brain Behav"},{"key":"10.1016\/j.pharmr.2025.100046_bib128","doi-asserted-by":"crossref","first-page":"171","DOI":"10.3389\/fpsyt.2020.00171","article-title":"Corrigendum: National prescription patterns of antidepressants in the treatment of adults with major depression in the US between 1996 and 2015: A population representative survey based analysis","volume":"11","author":"Luo","year":"2020","journal-title":"Front Psychiatry"},{"key":"10.1016\/j.pharmr.2025.100046_bib129","doi-asserted-by":"crossref","first-page":"395","DOI":"10.2174\/1570159043359477","article-title":"Buprenorphine: A unique drug with complex pharmacology","volume":"2","author":"Lutfy","year":"2004","journal-title":"Curr Neuropharmacol"},{"key":"10.1016\/j.pharmr.2025.100046_bib130","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1517\/14740330802423168","article-title":"Paroxetine: Safety and tolerability issues","volume":"7","author":"Marks","year":"2008","journal-title":"Expert Opin Drug Saf"},{"key":"10.1016\/j.pharmr.2025.100046_bib131","doi-asserted-by":"crossref","first-page":"331","DOI":"10.2174\/157015909790031201","article-title":"Serotonin-norepinephrine reuptake inhibitors for pain control: Premise and promise","volume":"7","author":"Marks","year":"2009","journal-title":"Curr Neuropharmacol"},{"key":"10.1016\/j.pharmr.2025.100046_bib132","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1038\/sj.npp.1301571","article-title":"Interaction between bdnf and serotonin: Role in mood disorders","volume":"33","author":"Martinowich","year":"2008","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pharmr.2025.100046_bib133","doi-asserted-by":"crossref","first-page":"2485","DOI":"10.1098\/rstb.2012.0212","article-title":"Beyond the monoaminergic hypothesis: Neuroplasticity and epigenetic changes in a transgenic mouse model of depression","volume":"367","author":"Massart","year":"2012","journal-title":"Philos Trans R Soc Lond B Biol Sci"},{"key":"10.1016\/j.pharmr.2025.100046_bib134","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1196\/annals.1290.016","article-title":"Maternal and fetal hypothalamic-pituitary-adrenal axes during pregnancy and postpartum","volume":"997","author":"Mastorakos","year":"2003","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.pharmr.2025.100046_bib135","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1038\/s41573-022-00421-7","article-title":"The promises and perils of psychedelic pharmacology for psychiatry","volume":"21","author":"McClure-Begley","year":"2022","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.pharmr.2025.100046_bib136","first-page":"1","article-title":"Antidepressant treatment of depression during pregnancy and the postpartum period","author":"McDonagh","year":"2014","journal-title":"Evid Rep Technol Assess (Full Rep)"},{"key":"10.1016\/j.pharmr.2025.100046_bib137","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1146\/annurev.neuro.22.1.105","article-title":"Stress and hippocampal plasticity","volume":"22","author":"McEwen","year":"1999","journal-title":"Annu Rev Neurosci"},{"key":"10.1016\/j.pharmr.2025.100046_bib138","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1111\/gbb.12215","article-title":"SERT and uncertainty: Serotonin transporter expression influences information processing biases for ambiguous aversive cues in mice","volume":"14","author":"McHugh","year":"2015","journal-title":"Genes Brain Behav"},{"key":"10.1016\/j.pharmr.2025.100046_bib139","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1177\/070674371005500405","article-title":"Antenatal depression and anxiety affect postpartum parenting stress: A longitudinal, prospective study","volume":"55","author":"Misri","year":"2010","journal-title":"Can J Psychiatry"},{"key":"10.1016\/j.pharmr.2025.100046_bib140","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1176\/ajp.2006.163.6.1026","article-title":"Internalizing behaviors in 4-year-old children exposed in utero to psychotropic medications","volume":"163","author":"Misri","year":"2006","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.pharmr.2025.100046_bib141","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.jad.2019.12.014","article-title":"The international prevalence of antidepressant use before, during, and after pregnancy: A systematic review and meta-analysis of timing, type of prescriptions and geographical variability","volume":"264","author":"Molenaar","year":"2020","journal-title":"J Affect Disord"},{"key":"10.1016\/j.pharmr.2025.100046_bib142","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.jad.2020.02.003","article-title":"Dose-effect of maternal serotonin reuptake inhibitor use during pregnancy on birth outcomes: A prospective cohort study","volume":"267","author":"Molenaar","year":"2020","journal-title":"J Affect Disord"},{"key":"10.1016\/j.pharmr.2025.100046_bib143","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1177\/0004867418762057","article-title":"Guidelines on treatment of perinatal depression with antidepressants: An international review","volume":"52","author":"Molenaar","year":"2018","journal-title":"Aust N Z J Psychiatry"},{"key":"10.1016\/j.pharmr.2025.100046_bib144","doi-asserted-by":"crossref","first-page":"3243","DOI":"10.1038\/s41380-022-01661-0","article-title":"The serotonin theory of depression: A systematic umbrella review of the evidence","volume":"28","author":"Moncrieff","year":"2023","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.pharmr.2025.100046_bib145","series-title":"Tricyclic Antidepressants","author":"Moraczewski","year":"2024"},{"key":"10.1016\/j.pharmr.2025.100046_bib146","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1523\/JNEUROSCI.22-02-00389.2002","article-title":"Dopamine uptake through the norepinephrine transporter in brain regions with low levels of the dopamine transporter: Evidence from knock-out mouse lines","volume":"22","author":"Mor\u00f3n","year":"2002","journal-title":"J Neurosci"},{"key":"10.1016\/j.pharmr.2025.100046_bib147","doi-asserted-by":"crossref","first-page":"6747","DOI":"10.1007\/s00216-021-03665-1","article-title":"Simultaneous serotonin and dopamine monitoring across timescales by rapid pulse voltammetry with partial least squares regression","volume":"413","author":"Movassaghi","year":"2021","journal-title":"Anal Bioanal Chem"},{"key":"10.1016\/j.pharmr.2025.100046_bib148","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1038\/npp.2011.67","article-title":"Selective serotonin reuptake inhibitors affect neurobehavioral development in the human fetus","volume":"36","author":"Mulder","year":"2011","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pharmr.2025.100046_bib149","series-title":"Epidemiology of Study Design","author":"Munnangi","year":"2022"},{"key":"10.1016\/j.pharmr.2025.100046_bib150","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.3389\/fphys.2018.01091","article-title":"The role of placental hormones in mediating maternal adaptations to support pregnancy and lactation","volume":"9","author":"Napso","year":"2018","journal-title":"Front Physiol"},{"key":"10.1016\/j.pharmr.2025.100046_bib151","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1038\/s41398-019-0644-x","article-title":"Meta-analysis of reward processing in major depressive disorder reveals distinct abnormalities within the reward circuit","volume":"9","author":"Ng","year":"2019","journal-title":"Transl Psychiatry"},{"key":"10.1016\/j.pharmr.2025.100046_bib152","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.cpr.2018.06.004","article-title":"Treatment of depression, anxiety, and trauma-related disorders during the perinatal period: A systematic review","volume":"66","author":"Nillni","year":"2018","journal-title":"Clin Psychol Rev"},{"key":"10.1016\/j.pharmr.2025.100046_bib153","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1017\/S1461145705005079","article-title":"Bupropion SR for the treatment of postpartum depression: A pilot study","volume":"8","author":"Nonacs","year":"2005","journal-title":"Int J Neuropsychopharmacol"},{"key":"10.1016\/j.pharmr.2025.100046_bib154","doi-asserted-by":"crossref","first-page":"20","DOI":"10.2165\/00003088-199018010-00002","article-title":"Plasma protein binding of drugs in pregnancy and in neonates","volume":"18","author":"Notarianni","year":"1990","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.pharmr.2025.100046_bib155","doi-asserted-by":"crossref","first-page":"2312","DOI":"10.3390\/ijms18112312","article-title":"Actions of brain-derived neurotrophic factor and glucocorticoid stress in neurogenesis","volume":"18","author":"Numakawa","year":"2017","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.pharmr.2025.100046_bib156","series-title":"Screening for Depression in Adults: An Updated Systematic Evidence Review for the U.S. Preventive Services Task Force [Internet]","author":"O\u2019Connor","year":"2016"},{"key":"10.1016\/j.pharmr.2025.100046_bib157","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1001\/jama.2018.20865","article-title":"Interventions to prevent perinatal depression: Evidence report and systematic review for the us preventive services task force","volume":"321","author":"O\u2019Connor","year":"2019","journal-title":"JAMA"},{"key":"10.1016\/j.pharmr.2025.100046_bib158","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1176\/appi.ajp.2011.11040553","article-title":"Persistent pulmonary hypertension of the newborn and selective serotonin reuptake inhibitors: Lessons from clinical and translational studies","volume":"169","author":"Occhiogrosso","year":"2012","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.pharmr.2025.100046_bib159","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1111\/j.1360-0443.2011.03552.x","article-title":"Sertraline delays relapse in recently abstinent cocaine-dependent patients with depressive symptoms","volume":"107","author":"Oliveto","year":"2012","journal-title":"Addiction"},{"key":"10.1016\/j.pharmr.2025.100046_bib252","doi-asserted-by":"crossref","DOI":"10.1097\/NMD.0000000000000257","article-title":"Antidepressants, pregnancy, and stigma: How we are failing mothers and babies","volume":"203","author":"Osborne","year":"2015","journal-title":"J Nerv Ment Dis"},{"key":"10.1016\/j.pharmr.2025.100046_bib160","doi-asserted-by":"crossref","first-page":"235","DOI":"10.2165\/00003088-199528030-00005","article-title":"Placental transfer of drugs administered to the mother","volume":"28","author":"Pacifici","year":"1995","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.pharmr.2025.100046_bib161","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1097\/EDE.0b013e318258fbb2","article-title":"Can nonrandomized studies on the safety of antidepressants during pregnancy convincingly beat confounding, chance, and prior beliefs?","volume":"23","author":"Palmsten","year":"2012","journal-title":"Epidemiology"},{"key":"10.1016\/j.pharmr.2025.100046_bib162","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/j.mcna.2019.02.009","article-title":"Psychopharmacology in pregnancy and breastfeeding","volume":"103","author":"Payne","year":"2019","journal-title":"Med Clin North Am"},{"key":"10.1016\/j.pharmr.2025.100046_bib163","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1097\/GRF.0b013e3181b52e20","article-title":"Antidepressant use during pregnancy: Current controversies and treatment strategies","volume":"52","author":"Payne","year":"2009","journal-title":"Clin Obstet Gynecol"},{"key":"10.1016\/j.pharmr.2025.100046_bib164","doi-asserted-by":"crossref","first-page":"175","DOI":"10.9740\/mhc.2018.07.175","article-title":"Kappa opioid receptor antagonism: Are opioids the answer for treatment resistant depression?","volume":"8","author":"Peckham","year":"2018","journal-title":"Ment Health Clin"},{"key":"10.1016\/j.pharmr.2025.100046_bib165","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1007\/s40262-016-0383-6","article-title":"Ketamine: A review of clinical pharmacokinetics and pharmacodynamics in anesthesia and pain therapy","volume":"55","author":"Peltoniemi","year":"2016","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.pharmr.2025.100046_bib166","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1017\/neu.2017.39","article-title":"A brief history of antidepressant drug development: From tricyclics to beyond ketamine","volume":"30","author":"Pereira","year":"2018","journal-title":"Acta Neuropsychiatr"},{"key":"10.1016\/j.pharmr.2025.100046_bib167","first-page":"713","article-title":"The new pregnancy and lactation labeling rule","volume":"41","author":"Pernia","year":"2016","journal-title":"Pharm Ther"},{"key":"10.1016\/j.pharmr.2025.100046_bib168","doi-asserted-by":"crossref","first-page":"e832","DOI":"10.1038\/tp.2016.102","article-title":"Electroconvulsive therapy and structural neuroplasticity in neocortical, limbic and paralimbic cortex","volume":"6","author":"Pirnia","year":"2016","journal-title":"Transl Psychiatry"},{"key":"10.1016\/j.pharmr.2025.100046_bib169","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1038\/sj.npp.1301574","article-title":"Stress, depression, and neuroplasticity: A convergence of mechanisms","volume":"33","author":"Pittenger","year":"2008","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pharmr.2025.100046_bib170","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2020.114251","article-title":"Identification of psychedelic new psychoactive substances (NPS) showing biased agonism at the 5-HT(2A)R through simultaneous use of \u03b2-arrestin 2 and miniG\u03b1(q) bioassays","volume":"182","author":"Pottie","year":"2020","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.pharmr.2025.100046_bib171","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1038\/s41593-018-0203-4","article-title":"Mapping projections of molecularly defined dopamine neuron subtypes using intersectional genetic approaches","volume":"21","author":"Poulin","year":"2018","journal-title":"Nat Neurosci"},{"key":"10.1016\/j.pharmr.2025.100046_bib172","series-title":"Antidepressant Use During Pregnancy: Considerations for the Newborn Exposed to SSRIs\/SNRIs","year":"2013"},{"issue":"Suppl 2","key":"10.1016\/j.pharmr.2025.100046_bib173","first-page":"S354","article-title":"Antidepressants, anxiolytics, and hypnotics in pregnancy and lactation","volume":"57","author":"Ram","year":"2015","journal-title":"Indian J Psychiatry"},{"key":"10.1016\/j.pharmr.2025.100046_bib174","doi-asserted-by":"crossref","first-page":"180","DOI":"10.4103\/0019-5545.82567","article-title":"Antidepressants: From maois to ssris and more","volume":"53","author":"Ramachandraih","year":"2011","journal-title":"Indian J Psychiatry"},{"key":"10.1016\/j.pharmr.2025.100046_bib175","doi-asserted-by":"crossref","first-page":"281","DOI":"10.2165\/00003088-200746040-00002","article-title":"The clinical pharmacokinetics of escitalopram","volume":"46","author":"Rao","year":"2007","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.pharmr.2025.100046_bib176","doi-asserted-by":"crossref","DOI":"10.4088\/JCP.19r12965","article-title":"Long-term effects of intrauterine exposure to antidepressants on physical, neurodevelopmental, and psychiatric outcomes: A systematic review","volume":"81","author":"Rommel","year":"2020","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.pharmr.2025.100046_bib177","doi-asserted-by":"crossref","first-page":"192","DOI":"10.3389\/fnbeh.2014.00192","article-title":"The behavioral and immunological impact of maternal separation: A matter of timing","volume":"8","author":"Roque","year":"2014","journal-title":"Front Behav Neurosci"},{"key":"10.1016\/j.pharmr.2025.100046_bib178","article-title":"Determining pharmacological selectivity of the kappa opioid receptor antagonist LY2456302 using pupillometry as a translational biomarker in rat and human","volume":"18","author":"Rorick-Kehn","year":"2014","journal-title":"Int J Neuropsychopharmacol"},{"key":"10.1016\/j.pharmr.2025.100046_bib179","doi-asserted-by":"crossref","first-page":"785","DOI":"10.7326\/M18-1480","article-title":"The cost-effectiveness of cognitive behavioral therapy versus second-generation antidepressants for initial treatment of major depressive disorder in the united states: A decision analytic model","volume":"171","author":"Ross","year":"2019","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.pharmr.2025.100046_bib180","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/j.neuint.2012.02.013","article-title":"Glutamate and GABA synthesis, release, transport and metabolism as targets for seizure control","volume":"61","author":"Rowley","year":"2012","journal-title":"Neurochem Int"},{"key":"10.1016\/j.pharmr.2025.100046_bib181","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1056\/NEJMoa052963","article-title":"Bupropion-SR, sertraline, or venlafaxine-XR after failure of SSRIs for depression","volume":"354","author":"Rush","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.pharmr.2025.100046_bib182","article-title":"Chronic fluoxetine increases extra-hippocampal neurogenesis in adult mice","volume":"18","author":"Sachs","year":"2014","journal-title":"Int J Neuropsychopharmacol"},{"key":"10.1016\/j.pharmr.2025.100046_bib183","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1038\/nrd2462","article-title":"Targeting the glutamatergic system to develop novel, improved therapeutics for mood disorders","volume":"7","author":"Sanacora","year":"2008","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.pharmr.2025.100046_bib184","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1586\/eem.12.33","article-title":"Neurobehavioral risk is associated with gestational exposure to stress hormones","volume":"7","author":"Sandman","year":"2012","journal-title":"Expert Rev Endocrinol Metab"},{"key":"10.1016\/j.pharmr.2025.100046_bib185","first-page":"37","article-title":"Serotonin norepinephrine reuptake inhibitors: A pharmacological comparison","volume":"11","author":"Sansone","year":"2014","journal-title":"Innov Clin Neurosci"},{"key":"10.1016\/j.pharmr.2025.100046_bib186","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1126\/science.1083328","article-title":"Requirement of hippocampal neurogenesis for the behavioral effects of antidepressants","volume":"301","author":"Santarelli","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.pharmr.2025.100046_bib187","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.4088\/JCP.13m08902","article-title":"Impact of prenatal exposure to serotonin reuptake inhibitors or maternal major depressive disorder on infant developmental outcomes","volume":"75","author":"Santucci","year":"2014","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.pharmr.2025.100046_bib188","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1176\/jnp.7.4.524","article-title":"The catecholamine hypothesis of affective disorders: A review of supporting evidence. 1965","volume":"7","author":"Schildkraut","year":"1995","journal-title":"J Neuropsychiatry Clin Neurosci"},{"key":"10.1016\/j.pharmr.2025.100046_bib189","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1038\/s41386-024-01862-x","article-title":"Efficacy and safety of aticaprant, a kappa receptor antagonist, adjunctive to oral SSRI\/SNRI antidepressant in major depressive disorder: Results of a phase 2 randomized, double-blind, placebo-controlled study","volume":"49","author":"Schmidt","year":"2024","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pharmr.2025.100046_bib190","first-page":"19","article-title":"The NMDA receptor channel: Molecular design of a coincidence detector","volume":"50","author":"Seeburg","year":"1995","journal-title":"Recent Prog Horm Res"},{"key":"10.1016\/j.pharmr.2025.100046_bib191","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pneurobio.2013.04.001","article-title":"Brain development in rodents and humans: Identifying benchmarks of maturation and vulnerability to injury across species","volume":"106\u2013107","author":"Semple","year":"2013","journal-title":"Prog Neurobiol"},{"key":"10.1016\/j.pharmr.2025.100046_bib192","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-019-53624-1","article-title":"Behavioural characterisation of chronic unpredictable stress based on ethologically relevant paradigms in rats","volume":"9","author":"Sequeira-Cordero","year":"2019","journal-title":"Sci Rep"},{"key":"10.1016\/j.pharmr.2025.100046_bib193","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1192\/bjp.172.6.527","article-title":"Cortical grey matter reductions associated with treatment-resistant chronic unipolar depression. Controlled magnetic resonance imaging study","volume":"172","author":"Shah","year":"1998","journal-title":"Br J Psychiatry"},{"key":"10.1016\/j.pharmr.2025.100046_bib194","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.jad.2013.10.036","article-title":"Augmentation of response and remission to serial intravenous subanesthetic ketamine in treatment resistant depression","volume":"155","author":"Shiroma","year":"2014","journal-title":"J Affect Disord"},{"key":"10.1016\/j.pharmr.2025.100046_bib195","article-title":"Association of high cortisol levels in pregnancy and altered fetal growth. Results from the MAASTHI, a prospective cohort study, Bengaluru","volume":"14","author":"Shriyan","year":"2023","journal-title":"Lancet Reg Health Southeast Asia"},{"key":"10.1016\/j.pharmr.2025.100046_bib196","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2019-1157","article-title":"In utero antidepressants and neurodevelopmental outcomes in kindergarteners","volume":"145","author":"Singal","year":"2020","journal-title":"Pediatrics"},{"key":"10.1016\/j.pharmr.2025.100046_bib197","doi-asserted-by":"crossref","first-page":"652","DOI":"10.4088\/JCP.v69n0419","article-title":"Changes in antidepressant metabolism and dosing across pregnancy and early postpartum","volume":"69","author":"Sit","year":"2008","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.pharmr.2025.100046_bib198","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/S0022-3565(24)38905-0","article-title":"Bupropion is a nicotinic antagonist","volume":"295","author":"Slemmer","year":"2000","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pharmr.2025.100046_bib199","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.genhosppsych.2008.10.002","article-title":"Success of mental health referral among pregnant and postpartum women with psychiatric distress","volume":"31","author":"Smith","year":"2009","journal-title":"Gen Hosp Psychiatry"},{"key":"10.1016\/j.pharmr.2025.100046_bib200","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.earlhumdev.2012.08.001","article-title":"Neurobehavioral assessment of infants born at term and in utero exposure to serotonin reuptake inhibitors","volume":"89","author":"Smith","year":"2013","journal-title":"Early Hum Dev"},{"key":"10.1016\/j.pharmr.2025.100046_bib201","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2023-074600","article-title":"Association between antidepressant use during pregnancy and miscarriage: A systematic review and meta-analysis","volume":"14","author":"Smith","year":"2024","journal-title":"BMJ Open"},{"key":"10.1016\/j.pharmr.2025.100046_bib202","doi-asserted-by":"crossref","first-page":"89","DOI":"10.5830\/CVJA-2016-021","article-title":"Physiological changes in pregnancy","volume":"27","author":"Soma-Pillay","year":"2016","journal-title":"Cardiovasc J Afr"},{"issue":"Suppl 1","key":"10.1016\/j.pharmr.2025.100046_bib203","first-page":"S11","article-title":"Fibromyalgia--pathways and neurotransmitters","volume":"24","author":"Stahl","year":"2009","journal-title":"Hum Psychopharmacol"},{"key":"10.1016\/j.pharmr.2025.100046_bib204","first-page":"159","article-title":"A review of the neuropharmacology of bupropion, a dual norepinephrine and dopamine reuptake inhibitor","volume":"6","author":"Stahl","year":"2004","journal-title":"Prim Care Companion J Clin Psychiatry"},{"key":"10.1016\/j.pharmr.2025.100046_bib205","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.ajp.2017.01.015","article-title":"Use of buprenorphine in treatment of refractory depression-a review of current literature","volume":"26","author":"Stanciu","year":"2017","journal-title":"Asian J Psychiatry"},{"key":"10.1016\/j.pharmr.2025.100046_bib206","doi-asserted-by":"crossref","first-page":"108","DOI":"10.3389\/fnins.2019.00108","article-title":"Evolution in the treatment of psychiatric disorders: From psychosurgery to psychopharmacology to neuromodulation","volume":"13","author":"Staudt","year":"2019","journal-title":"Front Neurosci"},{"key":"10.1016\/j.pharmr.2025.100046_bib207","doi-asserted-by":"crossref","first-page":"495","DOI":"10.31887\/DCNS.2011.13.4\/tsteimer","article-title":"Animal models of anxiety disorders in rats and mice: Some conceptual issues","volume":"13","author":"Steimer","year":"2011","journal-title":"Dial Clin Neurosci"},{"key":"10.1016\/j.pharmr.2025.100046_bib208","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1001\/jamainternmed.2022.4268","article-title":"Association of antidepressant use during pregnancy with risk of neurodevelopmental disorders in children","volume":"182","author":"Suarez","year":"2022","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.pharmr.2025.100046_bib209","series-title":"Monoamine Oxidase Inhibitors (MAOI)","author":"Sub Laban","year":"2022"},{"key":"10.1016\/j.pharmr.2025.100046_bib210","series-title":"Monoamine Oxidase Inhibitors (MAOI)","author":"Sub Laban","year":"2024"},{"key":"10.1016\/j.pharmr.2025.100046_bib211","series-title":"Impact of the DSM-IV to DSM-5 Changes on the National Survey on Drug Use and Health [Internet]","year":"2016"},{"key":"10.1016\/j.pharmr.2025.100046_bib212","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/S0006-3223(02)01368-9","article-title":"Estimates of nursing infant daily dose of fluoxetine through breast milk","volume":"52","author":"Suri","year":"2002","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.pharmr.2025.100046_bib213","doi-asserted-by":"crossref","first-page":"E1","DOI":"10.1038\/nature22084","article-title":"Effects of a ketamine metabolite on synaptic nmdar function","volume":"546","author":"Suzuki","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.pharmr.2025.100046_bib214","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1002\/dev.21631","article-title":"Maternal depression and cortisol in pregnancy predict offspring emotional reactivity in the preschool period","volume":"60","author":"Swales","year":"2018","journal-title":"Dev Psychobiol"},{"key":"10.1016\/j.pharmr.2025.100046_bib215","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.cellsig.2004.12.007","article-title":"Mechanisms of action of antidepressants: From neurotransmitter systems to signaling pathways","volume":"17","author":"Taylor","year":"2005","journal-title":"Cell Signal"},{"key":"10.1016\/j.pharmr.2025.100046_bib216","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1001\/archpsyc.63.11.1217","article-title":"Early onset of selective serotonin reuptake inhibitor antidepressant action: Systematic review and meta-analysis","volume":"63","author":"Taylor","year":"2006","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.pharmr.2025.100046_bib217","doi-asserted-by":"crossref","first-page":"86","DOI":"10.3389\/fnins.2015.00086","article-title":"The role of metabotropic glutamate receptor 5 in the pathogenesis of mood disorders and addiction: Combining preclinical evidence with human positron emission tomography (PET) studies","volume":"9","author":"Terbeck","year":"2015","journal-title":"Front Neurosci"},{"key":"10.1016\/j.pharmr.2025.100046_bib218","doi-asserted-by":"crossref","first-page":"2729","DOI":"10.3389\/fimmu.2019.02729","article-title":"Editorial: Fetal-maternal immune interactions in pregnancy","volume":"10","author":"Than","year":"2019","journal-title":"Front Immunol"},{"issue":"Suppl 1","key":"10.1016\/j.pharmr.2025.100046_bib219","doi-asserted-by":"crossref","first-page":"S9","DOI":"10.1055\/s-0030-1253365","article-title":"Mental illness, synapses and the brain\u2014behavioral disorders by a system of molecules within a system of neurons?","volume":"43","author":"Tretter","year":"2010","journal-title":"Pharmacopsychiatry"},{"key":"10.1016\/j.pharmr.2025.100046_bib220","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1001\/jamapsychiatry.2023.0041","article-title":"Timing of antidepressant discontinuation during pregnancy and postpartum psychiatric outcomes in denmark and norway","volume":"80","author":"Trinh","year":"2023","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.pharmr.2025.100046_bib221","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1038\/d41586-021-00187-9","article-title":"How ecstasy and psilocybin are shaking up psychiatry","volume":"589","author":"Tullis","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.pharmr.2025.100046_bib222","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1111\/j.1360-0443.2011.03440.x","article-title":"Randomized controlled trials in pregnancy: Scientific and ethical aspects. Exposure to different opioid medications during pregnancy in an intra-individual comparison","volume":"106","author":"Unger","year":"2011","journal-title":"Addiction"},{"key":"10.1016\/j.pharmr.2025.100046_bib223","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/1744-9081-5-11","article-title":"Evaluation of animal models of neurobehavioral disorders","volume":"5","author":"van der Staay","year":"2009","journal-title":"Behav Brain Funct"},{"key":"10.1016\/j.pharmr.2025.100046_bib224","doi-asserted-by":"crossref","DOI":"10.1016\/j.earlhumdev.2020.105075","article-title":"Intra-uterine exposure to selective serotonin reuptake inhibitors (SSRIs), maternal psychopathology, and neurodevelopment at age 2.5 years\u2014results from the prospective cohort SMOK study","volume":"147","author":"van der Veere","year":"2020","journal-title":"Early Hum Dev"},{"key":"10.1016\/j.pharmr.2025.100046_bib225","doi-asserted-by":"crossref","first-page":"203","DOI":"10.2165\/00003088-199324030-00003","article-title":"Clinical pharmacokinetics of selective serotonin reuptake inhibitors","volume":"24","author":"van Harten","year":"1993","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.pharmr.2025.100046_bib226","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1126\/science.adf0435","article-title":"Psychedelics promote neuroplasticity through the activation of intracellular 5-HT2a receptors","volume":"379","author":"Vargas","year":"2023","journal-title":"Science"},{"key":"10.1016\/j.pharmr.2025.100046_bib227","doi-asserted-by":"crossref","first-page":"115","DOI":"10.3892\/br.2017.930","article-title":"Human placental growth hormone in normal and abnormal fetal growth","volume":"7","author":"Velegrakis","year":"2017","journal-title":"Biomed Rep"},{"key":"10.1016\/j.pharmr.2025.100046_bib228","doi-asserted-by":"crossref","first-page":"677","DOI":"10.2165\/11318050-000000000-00000","article-title":"Effect of cytochrome P450 2D6 genotype on maternal paroxetine plasma concentrations during pregnancy","volume":"48","author":"Ververs","year":"2009","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.pharmr.2025.100046_bib229","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1001\/jamapsychiatry.2017.1727","article-title":"Association of antidepressant medication use during pregnancy with intellectual disability in offspring","volume":"74","author":"Viktorin","year":"2017","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.pharmr.2025.100046_bib230","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1038\/s41583-020-0367-2","article-title":"Psychedelic drugs: Neurobiology and potential for treatment of psychiatric disorders","volume":"21","author":"Vollenweider","year":"2020","journal-title":"Nat Rev Neurosci"},{"key":"10.1016\/j.pharmr.2025.100046_bib231","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.3389\/fpsyg.2017.01657","article-title":"Dynamic brains and the changing rules of neuroplasticity: Implications for learning and recovery","volume":"8","author":"Voss","year":"2017","journal-title":"Front Psychol"},{"key":"10.1016\/j.pharmr.2025.100046_bib232","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/S0006-8993(02)04162-8","article-title":"Effects of chronic stress on dendritic arborization in the central and extended amygdala","volume":"965","author":"Vyas","year":"2003","journal-title":"Brain Res"},{"key":"10.1016\/j.pharmr.2025.100046_bib233","doi-asserted-by":"crossref","DOI":"10.1016\/j.ynstr.2019.100198","article-title":"Allopregnanolone-based treatments for postpartum depression: Why\/how do they work?","volume":"11","author":"Walton","year":"2019","journal-title":"Neurobiol Stress"},{"key":"10.1016\/j.pharmr.2025.100046_bib234","doi-asserted-by":"crossref","first-page":"11044","DOI":"10.1523\/JNEUROSCI.2125-11.2011","article-title":"Repetitive transcranial magnetic stimulation enhances BDNF-TrkB signaling in both brain and lymphocyte","volume":"31","author":"Wang","year":"2011","journal-title":"J Neurosci"},{"key":"10.1016\/j.pharmr.2025.100046_bib235","article-title":"Efficacy of a single low dose of esketamine after childbirth for mothers with symptoms of prenatal depression: Randomised clinical trial","volume":"385","author":"Wang","year":"2024","journal-title":"BMJ"},{"key":"10.1016\/j.pharmr.2025.100046_bib236","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1176\/appi.ajp.161.6.1066","article-title":"Pooled analysis of antidepressant levels in lactating mothers, breast milk, and nursing infants","volume":"161","author":"Weissman","year":"2004","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.pharmr.2025.100046_bib237","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1523\/JNEUROSCI.4595-06.2007","article-title":"Impaired stress-coping and fear extinction and abnormal corticolimbic morphology in serotonin transporter knock-out mice","volume":"27","author":"Wellman","year":"2007","journal-title":"J Neurosci"},{"key":"10.1016\/j.pharmr.2025.100046_bib238","doi-asserted-by":"crossref","first-page":"2024","DOI":"10.1038\/s41590-024-01971-1","article-title":"Regulators of placental antibody transfer through a modeling lens","volume":"25","author":"Wessel","year":"2024","journal-title":"Nat Immunol"},{"key":"10.1016\/j.pharmr.2025.100046_bib239","series-title":"Depression and Other Common Mental Disorders","year":"2017"},{"key":"10.1016\/j.pharmr.2025.100046_bib240","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1007\/s00737-020-01050-y","article-title":"Factors associated with re-initiation of antidepressant treatment following discontinuation during pregnancy: A register-based cohort study","volume":"23","author":"Wikman","year":"2020","journal-title":"Arch Womens Ment Health"},{"key":"10.1016\/j.pharmr.2025.100046_bib241","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1176\/appi.ajp.2017.17040472","article-title":"The effect of a single dose of intravenous ketamine on suicidal ideation: A systematic review and individual participant data meta-analysis","volume":"175","author":"Wilkinson","year":"2018","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.pharmr.2025.100046_bib242","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/j.drudis.2018.11.007","article-title":"A new generation of antidepressants: An update on the pharmaceutical pipeline for novel and rapid-acting therapeutics in mood disorders based on glutamate\/GABA neurotransmitter systems","volume":"24","author":"Wilkinson","year":"2019","journal-title":"Drug Discov Today"},{"key":"10.1016\/j.pharmr.2025.100046_bib243","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.ynstr.2016.08.002","article-title":"The chronic mild stress (CMS) model of depression: History, evaluation and usage","volume":"6","author":"Willner","year":"2017","journal-title":"Neurobiol Stress"},{"key":"10.1016\/j.pharmr.2025.100046_bib244","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1038\/clpt.2009.160","article-title":"Pharmacotherapy for depressed pregnant women: Overcoming obstacles to gathering essential data","volume":"86","author":"Wisner","year":"2009","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.pharmr.2025.100046_bib245","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1001\/jamapsychiatry.2023.5648","article-title":"Prioritizing maternal mental health in addressing morbidity and mortality","volume":"81","author":"Wisner","year":"2024","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.pharmr.2025.100046_bib246","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1080\/17512433.2023.2198703","article-title":"Clinical pharmacological innovation in the treatment of depression","volume":"16","author":"Witkin","year":"2023","journal-title":"Expert Rev Clin Pharmacol"},{"key":"10.1016\/j.pharmr.2025.100046_bib247","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1038\/nrd1821","article-title":"Case history: The discovery of fluoxetine hydrochloride (Prozac)","volume":"4","author":"Wong","year":"2005","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.pharmr.2025.100046_bib248","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.jad.2017.05.003","article-title":"A systematic review and meta-regression of the prevalence and incidence of perinatal depression","volume":"219","author":"Woody","year":"2017","journal-title":"J Affect Disord"},{"key":"10.1016\/j.pharmr.2025.100046_bib249","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/s40263-018-0492-x","article-title":"Convergent mechanisms underlying rapid antidepressant action","volume":"32","author":"Zanos","year":"2018","journal-title":"CNS Drugs"},{"key":"10.1016\/j.pharmr.2025.100046_bib250","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.biopsych.2005.06.027","article-title":"Use of bupropion in combination with serotonin reuptake inhibitors","volume":"59","author":"Zisook","year":"2006","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.pharmr.2025.100046_bib251","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1038\/s41398-020-0704-2","article-title":"Chronic psychosocial stress during pregnancy affects maternal behavior and neuroendocrine function and modulates hypothalamic CRH and nuclear steroid receptor expression","volume":"10","author":"Zoubovsky","year":"2020","journal-title":"Transl Psychiatry"}],"container-title":["Pharmacological Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0031699725074460?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0031699725074460?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T04:02:45Z","timestamp":1777435365000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0031699725074460"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":252,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,5]]}},"alternative-id":["S0031699725074460"],"URL":"https:\/\/doi.org\/10.1016\/j.pharmr.2025.100046","relation":{},"ISSN":["0031-6997"],"issn-type":[{"value":"0031-6997","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Safety in treatment: Classical pharmacotherapeutics and new avenues for addressing maternal depression and anxiety during pregnancy","name":"articletitle","label":"Article Title"},{"value":"Pharmacological Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pharmr.2025.100046","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc. on behalf of American Society for Pharmacology and Experimental Therapeutics.","name":"copyright","label":"Copyright"}],"article-number":"100046"}}